These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9579224)

  • 1. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment.
    Letizia C; Cerci S; Centanni M; De Toma G; Subioli S; Scuro L; Scavo D
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):145-8. PubMed ID: 9579224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma levels of endothelin-1 in untreated Addison's disease.
    Letizia C; Centanni M; Scuro L; Canettieri G; Cerci S; De Ciocchis A; D'Ambrosio C; Scavo D
    Eur J Endocrinol; 1996 Dec; 135(6):696-9. PubMed ID: 9025715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of adrenomedullin in patients with adrenoleukodystrophy/adrenomyeloneuropathy.
    Letizia C; D'Erasmo E; Subioli S; Di Biase A; Benedetti S; Bizzarri C; Ubertini G; Cappa M
    Horm Res; 2005; 63(2):90-4. PubMed ID: 15711093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR
    Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addison's disease in pregnancy: Case report, management, and review of the literature.
    Margulies SL; Corrigan K; Bathgate S; Macri C
    J Neonatal Perinatal Med; 2020; 13(2):275-278. PubMed ID: 31744021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proceedings: Plasma renin activity in management of Addison's disease (author's transl)].
    Linquette M; Lefebvre J; Fossati P; Fourlinnie JC; Cappoen JP; Lecieux P
    Ann Endocrinol (Paris); 1975; 36(2):103-4. PubMed ID: 1190719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculous Addison's disease: lack of normalization of adrenocortical function after anti-tuberculous chemotherapy.
    Bhatia E; Jain SK; Gupta RK; Pandey R
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):355-9. PubMed ID: 9578827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addison's disease, psychosis, and the syndrome of inappropriate secretion of antidiuretic hormone.
    Lever EG; Stansfeld SA
    Br J Psychiatry; 1983 Oct; 143():406-10. PubMed ID: 6414566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM; Holmes SJ; Elliot JR; Donald RA; Espiner EA
    N Z Med J; 1994 Feb; 107(972):52-3. PubMed ID: 8115069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
    Oelkers W; Bähr V
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexuality and fertility in women with Addison's disease.
    Erichsen MM; Husebye ES; Michelsen TM; Dahl AA; Løvås K
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4354-60. PubMed ID: 20610594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addison's disease associated with hypokalemia: a case report.
    Abdalla M; Dave JA; Ross IL
    J Med Case Rep; 2021 Mar; 15(1):131. PubMed ID: 33761983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid replacement in Addison's disease.
    Thompson DG; Mason AS; Goodwin FJ
    Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adrenomedullin in patients with primary aldosteronism.
    Kato K; Kitamura K; Kuwasako K; Tanaka M; Ishiyama Y; Shimokubo T; Ichiki Y; Nakamura S; Kangawa K; Eto T
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):997-1000. PubMed ID: 8845081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.